FDA Drug Label · 2021

WEGOVY (semaglutide) injection, for subcutaneous use - Prescribing Information

Novo Nordisk (2021). WEGOVY (semaglutide) injection, for subcutaneous use - Prescribing Information. FDA Drug Label.

FDA Drug Label

Source: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b

Last reviewed September 19, 2026. By the PeptIQ team.

Peptides linked in PeptIQ Wiki

Semaglutide — community report

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.